PRINSES MAXIMA CENTRUM VOOR KINDERONCOLOGIE BV
- Country
- Netherlands
- Type
- Beneficiary
- Website
- www.prinsesmaximacentrum.nl
- Grants received
- 22
Funding record
- 22 grants on record
- €22,121,880.24 awarded in total
- 2011–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
- Horizon Europe Framework Programme
- European Research Council
- Seventh Framework Programme
- Horizon 2020 Framework Programme
12 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ST. ANNA KINDERKREBSFORSCHUNG GMBH
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN
- FAKULTNI NEMOCNICE V MOTOLE
- INSTITUT GUSTAVE ROUSSY
- OSLO UNIVERSITETSSYKEHUS HF
- OSPEDALE PEDIATRICO BAMBINO GESU
- REGION HOVEDSTADEN
- UNIVERSITAT ZURICH
Calls from this organisation
No published calls from this organisation.
Grants received
- Deciphering non-genetic determinants and targetability of cancer cell plasticity.
- Centre of Excellence for Precision Medicine in Pediatric Care
- The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
- Benchmarking AI to predict mutagenicity by combing chemical structure and genome-wide mutation data
- A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
- How is blood (re-)made? Regeneration of human hematopoietic stem cells after transplantation
- Integrated Glycomics for Cancer Precision Medicine
- International Study for Treatment of Childhood Relapsed ALL 2020
- Twinning in Research and Education to improve survival in Childhood Solid Tumours in Lithuania
- A novel platform for the direct profiling of circulating cell-free ribonucleic acids in biofluids
- What causes therapy-related malignancies in childhood cancer survivors? Dissecting the etiology of second cancers
- HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research
- Deciphering the cellular origin and evolution of malignant rhabdoid tumors
- Health effects of cArdiac fluoRoscopy and MOderN radIotherapy in paediatriCs
- PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.